Multiple functional domains of the heparin molecule

Area of Science:

• Biochemistry
• Pharmacology

Background:

• Heparin is a complex polysaccharide with anticoagulant properties.
• Its anticoagulant activity is mediated by antithrombin, a serine protease inhibitor.
• Understanding the structure-activity relationship of heparin fragments is crucial for developing targeted anticoagulants.

Purpose of the Study:

• To investigate the role of specific heparin oligosaccharide sizes in the inhibition of Factor Xa and thrombin by antithrombin.
• To determine the binding affinity and kinetic parameters of different heparin fragments with antithrombin.

Main Methods:

• Affinity fractionation of porcine heparin to isolate fragments of defined lengths (hexasaccharides, octasaccharides, decasaccharides, and mucopolysaccharide fragments ~14 and ~16 residues).
• Chemical scissioning of heparin to generate oligosaccharide fragments.
• Kinetic analysis of antithrombin-protease interactions in the presence of heparin fragments.

Main Results:

• Heparin fragments enhanced Factor Xa inactivation by antithrombin, with activity increasing with fragment size.
• Oligosaccharides showed minimal acceleration of thrombin-antithrombin interactions.
• Binding affinity (dissociation constants) for antithrombin increased with heparin fragment size.
• Fragments of approximately 14 and 16 residues were most effective in accelerating both thrombin and Factor Xa inactivation by antithrombin.

Conclusions:

• The antithrombin-binding domain of heparin is closely linked to its ability to catalyze Factor Xa inactivation.
• Heparin fragments of approximately 14-16 residues are optimal for accelerating both thrombin and Factor Xa inhibition by antithrombin.
• Larger heparin fragments may facilitate enzyme-inhibitor complex formation more effectively.